Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of bioactive molecules targeting central nervous system disorders. Its structure allows for selective modification of nitrogen-containing heterocycles, making it valuable in medicinal chemistry for creating analogs with improved metabolic stability and binding affinity. Commonly employed in the preparation of receptor agonists or antagonists, especially in research related to neurological and psychiatric conditions. Also utilized in solid-phase and solution-phase peptide-like compound synthesis due to the compatibility of the Boc (tert-butoxycarbonyl) protecting group with various reaction conditions.